Skip to main content

Table 1 Comparative analysis of cell death (%) of monolayer and spheroid ACC cells analyzed by MTS assay

From: The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells

 

Monolayer

Spheroids

Treatmenta

 Mitotane

10 μM

30 μM

10 μM

30 μM

 

0

86.9

0

15.4

 Mitotaneb

   

48.1

 

+ Mitotane (10 μM)

+ Mitotane (30 μM)

Everolimus (10 μM)

29.7

49.3

0

32.1

Sunitinib (5 μM)

58.2

76.2

20.3

23.6

Zol Acid (10 μM)

19.5

30.1

0

0

Imatinib (10 μM)

27.2

50.3

0

18.1

Nilotinib (10 μM)

62.8

70.2

39.6

56.0

Nilotinibb (10 μM)

67.2

62.5

62.0

60.0

  1. ACC adrenocortical carcinoma
  2. aFor 72 h
  3. bACC-T36